Plunkett Research Online: BioMerieux SA

BIOMERIEUX SA (BMXXY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about.....


BIOMERIEUX SA

Ticker: BMXXY
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 33 478872000
Fax: 33 478872090
Address: Marcy l’Etoile
Lyon, 69280 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Alexandre MerieuxCEO/Chmn.
Guillaume BouhoursCFO
See More
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture